79 related articles for article (PubMed ID: 11117084)
1. Nuchal thickness evolution in trisomy 18 fetuses.
Borrell A; Farré MT; Echevarría M; Martinez JM; Costa D; Fortuny A
Ultrasound Obstet Gynecol; 2000 Aug; 16(2):146-8. PubMed ID: 11117084
[TBL] [Abstract][Full Text] [Related]
2. Natural evolution of nuchal thickness in trisomy-21 fetuses.
Borrell A; Costa D; Martinez JM; Farré MT; Cararach J; Fortuny A
Obstet Gynecol; 1998 Jan; 91(1):78-81. PubMed ID: 9464725
[TBL] [Abstract][Full Text] [Related]
3. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome.
Locatelli A; Piccoli MG; Vergani P; Mariani E; Ghidini A; Mariani S; Pezzullo JC
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):192-7. PubMed ID: 10649178
[TBL] [Abstract][Full Text] [Related]
4. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
5. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
[TBL] [Abstract][Full Text] [Related]
6. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
7. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
Snijders RJ; Sebire NJ; Nayar R; Souka A; Nicolaides KH
Am J Med Genet; 1999 Sep; 86(3):205-7. PubMed ID: 10482866
[TBL] [Abstract][Full Text] [Related]
8. First-trimester fetal nuchal translucency thickness and risk for trisomies.
Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
[TBL] [Abstract][Full Text] [Related]
9. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
10. Early resolution of increased nuchal translucency in a fetus with trisomy 18.
Celentano C; Di Donato NG; Prefumo F; Rotmensch S
Am J Obstet Gynecol; 2003 Sep; 189(3):880-1. PubMed ID: 14526334
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of trisomy 18 at the 10-14-week ultrasound scan.
Sherod C; Sebire NJ; Soares W; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1997 Dec; 10(6):387-90. PubMed ID: 9476321
[TBL] [Abstract][Full Text] [Related]
12. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
[TBL] [Abstract][Full Text] [Related]
13. The impact of gestational age on the sonographic detection of aneuploidy.
Picklesimer AH; Moise KJ; Wolfe HM
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1243-7. PubMed ID: 16157145
[TBL] [Abstract][Full Text] [Related]
14. The effect of fetal neck position on nuchal fold thickness.
Olson G; Saade GR; Zlatnik M; Dildy GA; Belfort M
Am J Obstet Gynecol; 2000 Oct; 183(4):995-7. PubMed ID: 11035352
[TBL] [Abstract][Full Text] [Related]
15. [Nuchal cord and nuchal translucency measurements between 10th and 14th weeks of gestation].
Czekierdowski A; Sodowski K; Cnota W; Kraczkowski J
Ginekol Pol; 2001 Dec; 72(12A):1596-601. PubMed ID: 11883322
[TBL] [Abstract][Full Text] [Related]
16. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
Hyett JA; Noble PL; Snijders RJ; Montenegro N; Nicolaides KH
Ultrasound Obstet Gynecol; 1996 Apr; 7(4):239-44. PubMed ID: 8726874
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
[TBL] [Abstract][Full Text] [Related]
18. Correlation between nuchal thickness and abnormal karyotype in first trimester fetuses.
Hewitt BG; de Crespigny L; Sampson AJ; Ngu AC; Shekleton P; Robinson HP
Med J Aust; 1996 Oct; 165(7):365-8. PubMed ID: 8890842
[TBL] [Abstract][Full Text] [Related]
19. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
20. Three- versus two-dimensional ultrasound for nuchal translucency thickness measurements: comparison of feasibility and levels of agreement.
Eppel W; Worda C; Frigo P; Lee A
Prenat Diagn; 2001 Jul; 21(7):596-601. PubMed ID: 11494299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
